Related Experiment Video
Updated: Jan 29, 2026

Characterizing Mutational Load and Clonal Composition of Human Blood
Published on: July 11, 2019
Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study
Xiaoyan Liao1,2, Yansheng Hao1, Xiaofei Zhang1
1Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Abstract:
The SMAD4 tumor suppressor gene product inhibits transforming growth factor-β-mediated signaling and is mutated in ~10% of colorectal carcinomas. The prognostic significance of SMAD4 mutations has been controversial. We studied the pathological and clinical characteristics of SMAD4-mutated intestinal adenocarcinomas using a retrospective case-control study design. Cases and controls were identified among 443 primary adenocarcinomas that had undergone next generation DNA sequencing (NGS) with the Ion AmpliSeq Cancer Hotspot Panel v2, which evaluates 50 cancer-related genes. Twenty-eight SMAD4-mutated (SMAD4m) patients were matched 1:2 with 56 consecutive SMAD4 wild-type (SMAD4wt) control patients from the same analysis stream. Compared with the SMAD4wt controls, the SMAD4m tumors were of higher stage (P = 0.026) and were more likely to feature mucinous differentiation (P = 0.0000), to occur in the setting of Crohn's disease (P = 0.0041), and to harbor concurrent RAS mutations (P = 0.0178). Tumor mucin content was significantly correlated with mutations involving the MH2 domain of the SMAD4 protein (P = 0.0338). Correspondence between mutation sites and morphology was demonstrated directly in a mixed adenocarcinoma and neuroendocrine tumor where SMAD4 mutations involving different protein domains were found in histologically disparate tumor regions despite both containing identical KRAS and TP53 mutations.
Insights
SMAD4 gene mutations in colorectal cancer are linked to higher tumor stage and mucinous differentiation. These findings clarify the prognostic significance of SMAD4 mutations in intestinal adenocarcinomas.
Area of Science:
- Oncology
- Genetics
- Gastroenterology
Background:
- The SMAD4 tumor suppressor gene regulates transforming growth factor-β signaling.
- SMAD4 mutations occur in approximately 10% of colorectal carcinomas, but their prognostic impact remains debated.
- Understanding SMAD4 mutation characteristics is crucial for colorectal cancer prognosis.
Purpose of the Study:
- To investigate the clinicopathological features of SMAD4-mutated intestinal adenocarcinomas.
- To compare SMAD4-mutated tumors with SMAD4 wild-type tumors to identify distinct characteristics.
- To explore the correlation between SMAD4 mutation sites and tumor morphology.
Main Methods:
- Retrospective case-control study of 443 primary adenocarcinomas.
- Next-generation DNA sequencing (NGS) using the Ion AmpliSeq Cancer Hotspot Panel v2.
- Matching of 28 SMAD4-mutated (SMAD4m) patients with 56 SMAD4 wild-type (SMAD4wt) controls.
Main Results:
- SMAD4m tumors exhibited higher pathological stage (P = 0.026).
- SMAD4m tumors were more frequently associated with mucinous differentiation (P = 0.0000), Crohn's disease (P = 0.0041), and concurrent RAS mutations (P = 0.0178).
- Tumor mucin content correlated with mutations in the SMAD4 protein's MH2 domain (P = 0.0338).
Conclusions:
- SMAD4 mutations are associated with specific pathological and clinical features in colorectal adenocarcinomas.
- These findings contribute to clarifying the prognostic significance of SMAD4 mutations.
- Demonstrated a direct link between SMAD4 mutation sites and distinct histological features within tumors.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Mutation, Gene Flow, and Genetic Drift

